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Abstract
A remembrance of Andy Kaplan as a colleague, a friend, and a member of our community.
Obituary
It is with great sadness that I write of the death of Dr.
Andrew Kaplan, Associate Professor of Medicine and of
Microbiology and Immunology, University of North
Carolina at Chapel Hill, at the age of 47. Andy died sud-
denly on June 28, 2006 from unrecognized heart disease.
We will miss Andy for his warmth, his wit, his intelli-
gence, and his commitment to the retrovirology commu-
nity.
Andy had strong academic training with an undergraduate
degree from Harvard and a medical degree from Colum-
bia. He did his residency training at UNC Chapel Hill then
stayed for a fellowship in infectious diseases. I first met
him as a fellow when he chose my lab for training in HIV
molecular biology.
Those who trained in medicine at this time were among
the first group of researchers confronted with the HIV epi-
demic. Andy's medical school training in New York in the
early 1980s brought him into contact with AIDS at a time
when little was known and treatment didn't exist. The
AIDS Clinical Trials Unit was founded at UNC just as
Andy was finishing his residency and becoming an ID Fel-
low. Both the need and the challenge drew him to this
emerging field.
Andy joined my lab as a fellow around 1990. In his initial
work he examined the site of processing of the HIV-1 Gag
protein. He was able to show that the full range of Gag
processing intermediates were present at the plasma
membrane, suggesting processing is at least initiated dur-
ing the budding process. This was a fortuitous time to be
working on questions involving the viral protease as the
first protease inhibitors were being developed. Due to a
generous collaboration with Dr. Dale Kempf at Abbott,
Andy was able to carry out some of the first selections for
resistance to a viral protease inhibitor, and with the assist-
ance of other members of the lab identified residues
within the protease involved in resistance. Further studies
with a protease inhibitor included an exploration of the
extent of processing inhibition needed to ablate virion
infectivity.
In 1993 Andy moved to UCLA as an assistant professor.
He continued studies in molecular virology with one
example being the novel observation of the discovery of a
primary infection case where the transmitted virus carried
a deleterious mutation which subsequently reverted. Dur-
ing this time his lab also initiated studies into the nature
of the dimer linkage structure of MLV, and his propensity
to participate in large collaborative studies started to
become apparent with colleagues at UCLA.
Prior to leaving UNC Andy married Carol Golin, an MD
researcher interested in issues of adherence to therapy.
They found overlapping interests in the study of the rela-
tionship of adherence to the development of drug resist-
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ance, a line of research for which they received joint
funding. These studies also represented a significant
expansion of Andy's scientific interests into the area of
behavioral science.
We were fortunate to recruit Andy and Carol back to UNC
in 1998. Andy continued his studies in molecular virology
with research on the HIV protease autoactivation and the
dimer interface. He remained deeply steeped in the use of
mutagenesis linked to high throughput assays for func-
tion to address fundamental questions about the viral
protease.
In the last few years Andy's intellectual breadth became
fully apparent as did his role as a mentor and collabora-
tor. He made contributions to the development of a larger
UNC effort to study acute infections across the entire state.
He also provided senior leadership to a novel set of stud-
ies following the impact on behavior, therapy and care of
incarcerated persons who return to their communities.
Andy was an active member of our research community.
He gave freely of his time to serve on any number of study
sections. I frequently relied on his commitment to peer
review as a reviewer for the Journal of Virology, always
grateful for his thoughtful reviews. Over the last year he
was one of the most active reviewers for JV. Andy was one
of a very small number of MDs who made a point of
attending the Cold Spring Harbor Retrovirus Meeting held
each May. Presentations at this meeting have been a rite-
of-passage for young retrovirologists for thirty years and
Andy continued to contribute to this unique and valuable
meeting that is an essential gathering of our molecular
virology community.
In my mind Andy will always be the person who would go
out for a lunchtime run with me at CSH. He was wonder-
ful company with a mind full of curiosity and interest in
the topic of the day and happy to carry the conversation
on the uphill stretches. After running the obligatory 4
miles down to the beach and back, Andy would deliver
me back to Blackford then head out for the rest of his run,
ever expecting more of himself.
We have established The Andy Kaplan Memorial Lecture-
ship within the Infectious Diseases Division here at UNC
Chapel Hill. For those of you wishing to remember Andy
by contributing to this effort please send a check to The
Andy Kaplan Fund, mailed to LouAnne Loschin, ID Divi-
sion CB 7030, Department of Medicine. Rm 2118D Bio-
informatics Bldg., University of North Carolina at Chapel
Hill, Chapel Hill, NC, 27599.
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